Business Context and Reporting Period
This Form 8-K is a current report filed by Nephros, Inc. on February 4, 2009. The filing addresses a change in the trading venue for the company's common stock following a suspension of trading on a national exchange.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance and trading status updates.
Material Changes
- Trading Suspension: Trading of Nephros, Inc. common stock was suspended by NYSE Alternext US LLC (formerly the American Stock Exchange) on January 22, 2009.
- New Trading Venue: Effective February 4, 2009, the common stock is now quoted on the Over the Counter (OTC) Bulletin Board.
- New Symbol: The stock trades under the symbol NEPH.OB.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or specific risk factors beyond the implication of the trading suspension and subsequent move to the OTC market. No unusual items or contingencies are disclosed in this specific report.
Investor Verification Checklist
- Verify the current trading symbol NEPH.OB on the OTC Bulletin Board.
- Confirm the reasons for the trading suspension by NYSE Alternext US LLC on January 22, 2009, by reviewing prior filings or press releases.
- Review the company's most recent 10-K or 10-Q for financial health metrics, as this 8-K does not contain financial data.